DEVICE CATEGORY · LYJ
Stimulator, Autonomic Nerve, Implanted For Epilepsy
FDA classification: Unknown. Device class 3.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VNS Therapy SystemP970003/S254 | LivaNova USA, Inc. | PMA supplement | Oct 2, 2026 | FDA |
VNS Therapy SystemP970003/S249 | LivaNova USA, Inc. | PMA supplement | Aug 12, 2026 | FDA |
VNS Therapy SystemP970003/S253 | LivaNova USA, Inc. | PMA supplement | Mar 4, 2026 | FDA |
VNS THERAPY SYSTEMP970003/S252 | LivaNova USA, Inc. | PMA supplement | Dec 17, 2025 | FDA |
| LivaNova USA, Inc. | PMA supplement | Nov 25, 2025 | FDA | |
VNS Therapy SystemP970003/S250 | LivaNova USA, Inc. | PMA supplement | Sep 12, 2025 | FDA |
VNS Therapy SystemP970003/S248 | LivaNova USA, Inc. | PMA supplement | Sep 5, 2025 | FDA |
VNS THERAPY SYSTEMP970003 | LivaNova USA, Inc. | PMA approval | Jul 16, 1997 | FDA |
Source information
Follow the FDA links to view the original records.




